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Background & Objective: Squamous cell carcinoma (SCC) is the second most 
common non-melanoma skin cancer that may be caused by Human papillomavirus 
(HPV), especially in immunosuppressed patients. However, the role of the mucosal 
types of HPV in SCC patients with normal immunity has not been extensively 
confirmed. The aim of this study was to investigate the association of some high-risk 
mucosal types of HPV with cutaneous SCC in an Iranian population.   
Methods: Sixty-five formalin-fixed, paraffin-embedded tissue specimens with a 
diagnosis of cutaneous SCC as the case group and sixty-five healthy skin specimens as 
the control group were included in our case-control study. Genomic DNA was extracted 
from tissue samples and then PCR was used for the detection of HPV genotypes by a 
commercial kit. 
Results: Our data revealed that 6 out of 65 SCC samples (9.2%) were infected by high-
risk mucosal types of HPV whereas none of the 65 control samples were infected by 
the mentioned HPVs. Statistical analysis showed a significant association between 
these types of HPV infection and SCC risk in our studied population (P=0.028).  
Conclusion: These findings suggested that some high-risk mucosal types of HPV are 
significant risk factors for cutaneous SCC. 
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Introduction 
Squamous cell carcinoma (SCC) is the second most 
common skin malignancy after basal cell carcinoma 
(BCC), and its prevalence is increasing in many 
countries (1). SCC affects every part of the skin and 
mucosa with squamous epithelium, especially areas 
exposed to sunlight, such as the face, hands, and arms 
(2). Other risk factors of this disease are light skin, aging, 
chronic ulcers, male gender, actinic keratosis as a 
precursor of skin cancer, and a Human papillomavirus 
(HPV) infection (3). 
HPV is a member of the papillomaviridae that has a 
circular double-stranded DNA with approximately 8kbp 
length (1), and consists of more than 100 different types 
of viruses that target squamous cells (4, 5). Oncoproteins 
E6 and E7 of this virus prevent apoptosis by binding to 
the P53 and pRb tumor suppressor genes in target cells, 
thus playing a pathogenic and progressive role in 
malignant changes (6). High-risk types of HPV cause 
cervical, anogenital, and oropharyngeal cancers, 
whereas cutaneous types are mainly related to benign 
and malignant skin lesions; some mucosal HPV types 
have been detected in skin malignancies (5). HPV18, 16, 
and 56, the common types of high risk mucosal HPV, 
have been frequently found in non-melanoma skin 
cancers (4, 7-9). Although the main cause of non-
melanoma skin cancer is exposure to UV radiation, 
cutaneous HPV can also contribute to carcinogenesis 
with UV radiation (10).  
Studies in immunodeficient individuals have 
confirmed the role of HPV in skin SCC, but this effect 
has not yet been extensively studied in people with 
normal immunity (4). There is a strong association 
between HPV 5 and HPV 8, and the incidence of non-
melanoma skin cancers in Epidermodysplasia 
verruciformis (EV), in which individuals are susceptible 
to multiple skin warts, and in which about 30-40% of 
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infected individuals develop squamous cell carcinoma in 
areas of the skin exposed to the sun (11). In order to 
tackle the prevalence of SCC, the need for further 
research on its causes in an effort to find effective 
strategies for prevention and treatment, we investigated 
the association of high-risk HPVs with SCC in an 
Iranian population.  
Materials and Methods 
Samples 
This case-control study was performed on the 
paraffin blocks of 65 patients with SCC as the case group 
and 65 healthy pilonidal sinus samples as the control 
group. Participants were referred to the pathology 
department of Shahid Beheshti Hospital, Kashan 
University of Medical Sciences (Kashan, Iran) during 
the years 2011-2017 and SCC diagnosis was confirmed 
by the pathologist. To control the main confounding 
variable, subjects with immunosuppressive diseases, a 
history of transplantation, and immunodeficiency were 
excluded from the study. Also, other possible 
confounding variables such as age, sex, and location of 
the lesion were matched between healthy and patient 
groups. 
DNA Extraction 
The most suitable paraffin blocks were selected, then 
10 cross-sectional cuts of each block with a thickness of 
3-5 μm were prepared under sterile conditions by 
microtome. After transferring the samples to microtubes 
and deparaffinization, DNA extraction steps were 
performed according to the DNA-Sorb-C kit’s 
(AmpliSens biotechnologies, Russia) instruction manual. 
Detection of HPV Genotypes  
After DNA extraction, 14 high-risk HPV genotypes 
were detected using an AmpliSens® HPV HCR 
genotype-titre-FRT PCR kit variant FRT-100 
(AmpliSens®/Russia) within a DT-96 Real-Time PCR 
Cycler (DNA- Technology, Russia). The Beta-globin 
gene was used as an internal control to ensure proper 
DNA extraction. To carry out Real-time PCR, the entire 
volume of Taq F (60 μL) solution was initially mixed 
with 600 μL of PCR buffer B. Then 5μL of this mixture 
was added to 10 μL of four types of PCR mix F1 HPV 
(mix 16, 18, 31, Glob; mix 39, 45, 59, Glob; mix 33, 35, 
56, 68; mix 51, 52, 58, 66). Of the four prepared 
solutions, 15 μL was added to each micro-tube 
containing DNA samples. Data analysis was performed 
using real-time PCR software by measuring the 
fluorescence signals obtained from 4 channels as 
follows: The DNA amplification signal for HPV types 
58, 33, 39, 16 was identified in the FAM fluorescence 
channel. The DNA amplification signal for HPV types 
52, 35, 45, 31 was detected in the JOE fluorescence 
channel. The DNA amplification signal for HPV types 
66, 68, 59, 18 was identified in the ROX fluorescence 
channel. The DNA amplification signal for HPV types 
51, 56 appeared in the Cy5 fluorescence channel. 
Finally, the internal control signal was detected by the 
Cy5 fluorescence channel in the microtubes containing 
PCR-mix F1 HPV 16, 18, 31/Glob and PCR-mix-F1 
HPV 39, 45, 59/Glob. 
Statistical Analysis 
Data was collected and entered into SPSS version 
19.0 (SPSS Inc., IBM Corp. Armonk, NY, USA). 
Independent t-test was used to analyze numerical data. 
Differences between the case and control groups 
regarding qualitative data, as well as genotype 
frequencies, were analyzed by χ2 test. P-values less than 
0.05 were considered statistically significant. 
Results 
Of all patients with SCC, 53 (81.5%) and 12 
(18.5%) individuals were respectively male and 
female, which indicates a higher incidence of SCC in 
men. In addition, the most common site of SCC lesions 
was observed in the head, neck, face, and hands, which 
are areas exposed to sunlight (87%). Out of 65 patients 
with SCC in this study, 6 (2.9%) were HPV-positive, 
while none of the controls were positive (0.0%). 
Statistical analysis showed significant differences 
between case and control groups regarding HPV 
infection (P<0.05). 
Of 14 high-risk studied HPV genotypes (16, 18, 31, 
33, 35, 39, 45, 51, 52, 56, 58, 59, 66, 68), HPV 51 and 
52 were observed in two SCC subjects but HPV 31 and 
16 were observed in one SCC subject. Also, the most 
common HPV-positive sites of SCC lesions were the 
neck and face (Table 1). Of all patients with SCC who 
were also HPV-positive, four and two cases were 
respectively male and female (Table 1). 
 
 
Table 1. HPV virus frequency and its genotypes in the SCC group based on the location of the lesion and gender 
Lesion Region Total No. 
HPV positive HPV negative 
     No (genotypes) % No. % 
Head, Neck & Face 50 5 (51, 52, 52, 31, 16) 10 45 90 
Hand 7 0 0 7 100 
Foot 4 1 (51) 25 3 75 
Knee & Thigh 3 0 0 3 100 
Chest 1 0 0 1 100 
                       Gender 
Male 53 4 (31, 51, 52,52) 7.55 49 92.45 
Female 12 2 (51, 16) 16.67 10 83.33 
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Discussion 
In this study, we investigated the presence of HPV 
high-risk types in patients with squamous cell 
carcinoma. Our study showed 9.23% of all patients 
with SCC were HPV-positive while none of the control 
group was HPV-positive. As seen, the incidence of 
HPV-infected cases in SCC patients was significantly 
higher than in healthy skin samples. According to 
previous studies, Shayanfar et al. (2013) found the 
DNA of HPV 18, 11, and 6 in 30% of malignant 
specimens of SCC while this level was reported to be 
11% in controls that suggest an association between 
HPV infection and SCC risk (4). In a study on paraffin 
blocks of non-melanoma skin cancers and benign skin 
lesions, Shahmahmoudi et al. (2007) identified the 
DNA of HPV 18, 16, and 56 in 25.7% of malignant 
samples compared with 0.7% of benign ones (5). In a 
study on SCC biopsy specimens, Iftner et al. (2003) 
observed the DNA of HPV 16, 31, 35, and 51 in 59.7% 
of patients and 4.7% of controls (9).  
As mentioned, in some studies there was a 
significant association between HPV infection and 
SCC risk (4, 5). Also, the results of our study showed 
the possible role of HPV, especially types 16, 31, 51 
and 52, in the development of SCC in Iranian patients. 
In some studies investigating the cutaneous HPV, there 
was a significant association between HPV infection 
and SCC risk (11-14) but some other studies reported 
no significant association (15-17). It seems that the 
inconsistent outcomes in different studies may be due 
to several factors such as the HPV genotypes 
(cutaneous or mucosal) and genotypes, virus 
identification method (serology or tissue study), 
sample type (paraffin blocks or fresh tissue), 
epidemiological factors, and the prevalence of HPV in 
different geographical regions. The controversial 
outcomes of HPV association with SCC require further 
studies to arrive at more comprehensive results.  
There are some limitations in our study which 
should be noted. At first, we did not evaluate the 
cutaneous HPV types in our studied population. Also, 
we did not assess the high-risk HPV in benign skin 
lesions. In addition, we only employed the real-time 
PCR for HPV typing. However, proving the 
association between HPV and cutaneous SCC requires 
more experimental studies to determine the 
transcriptional activity of HPV in squamous cell 
carcinoma. Serological studies, HPV protein marker 
detection, and PCR being used simultaneously on SCC 
specimens, as well as studies on more patients in 
different geographical regions, can provide a better 
perspective of HPV’s role in SCC. 
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